Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast cancer liver metastasis: current and future treatment approaches
Narmeen S Rashid, Jacqueline M. Grible, Charles V. Clevenger, et al.
Clinical & Experimental Metastasis (2021) Vol. 38, Iss. 3, pp. 263-277
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Nanodrug Augmenting Antitumor Immunity for Enhanced TNBC Therapy via Pyroptosis and cGAS-STING Activation
Huihai Zhong, Gengjia Chen, Tan Li, et al.
Nano Letters (2023) Vol. 23, Iss. 11, pp. 5083-5091
Closed Access | Times Cited: 46
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer
Jingjun Sun, Haiyan Zhao, Weixuan Xu, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 33
Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208
Jinzhu Han, Xuyi Chen, Jianlong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 21
Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis
Nirmala G. Sannappa Gowda, Varsha D. Shiragannavar, Lakshana D. Puttahanumantharayappa, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 17
ROS mediated Cu[Fe(CN)5NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model
Sanchita Tripathy, Shagufta Haque, Swapnali Londhe, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213832-213832
Closed Access | Times Cited: 7
Revolutionizing Cancer Detection: Harnessing Quantum Dots and Graphene-Based Nanobiosensors for Lung and Breast Cancer Diagnosis
Soheil Sadr, Abbas Rahdar, Sadanand Pandey, et al.
BioNanoScience (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 6
A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu4O3 nanoparticles or zinc oxide nanoparticles for efficient eradication of metastatic breast cancer
Marwa M. Abu‐Serie, Eisayeda Zeinab A. Abdelfattah
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
19F MRI/CEUS Dual Imaging‐Guided Sonodynamic Therapy Enhances Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
Qiu Chen, Hong Xiao, Lijun Hu, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil
Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, et al.
Cancer Treatment and Research Communications (2023) Vol. 35, pp. 100683-100683
Open Access | Times Cited: 12
Research progress of exosomes in drug resistance of breast cancer
Lihui Liu, Daqing Jiang, Shi Bai, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 4
Altered gut microbiome drives heightened pain sensitivity in a murine model of metastatic triple-negative breast cancer
Rajib Dutta
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 274-299
Open Access | Times Cited: 4
A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors
Shailima Rampogu, Mugahed A. Al-antari, Tae Hwan Oh, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Co-occurrence of breast cancer and malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1
Naoki Sugimura, S Takao, Akiko Okamoto, et al.
International Cancer Conference Journal (2025) Vol. 14, Iss. 2, pp. 177-184
Closed Access
A tailored 4G s-triazine-based dendrimer vehicle for quercetin endowed with MMP-2/9 inhibition and VEGF downregulation for targeting breast cancer progression and liver metastasis
Doaa R. Ramadan, Heba Ahmed Osman, Somaya Aly Madhy, et al.
RSC Advances (2025) Vol. 15, Iss. 13, pp. 10426-10441
Open Access
Dual-Targeting of Tumor Cells and Tumor-Associated Macrophages by Palmitic Acid Modified Albumin Nanoparticles for Antitumor and Antimetastasis Therapy
Jiaxing Feng, Xiang Ling, Changlong Fang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 13, pp. 14887-14902
Closed Access | Times Cited: 17
Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities
Chunyan Yan, Menglu Zhao, Ya-Nan Wei, et al.
Molecular Therapy — Oncolytics (2023) Vol. 28, pp. 212-229
Open Access | Times Cited: 9
Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature
Gal Sadlik, Redmond‐Craig Anderson, Xiaomeng Lei, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 3, pp. 1004-1014
Open Access | Times Cited: 3
Liver Metastatic Breast Cancer: Epidemiology, Dietary Interventions, and Related Metabolism
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2376-2376
Open Access | Times Cited: 14
Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgery
Li Chen, Chunlei Tan, Qingwen Li, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21772-e21772
Open Access | Times Cited: 8
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Biochemical Pharmacology (2023) Vol. 212, pp. 115565-115565
Closed Access | Times Cited: 7
Migration speed of captured breast cancer subpopulations correlates with metastatic fitness
Nicolas Desjardins‐Lecavalier, Matthew G. Annis, Alexander Nowakowski, et al.
Journal of Cell Science (2023) Vol. 136, Iss. 13
Closed Access | Times Cited: 7
RUNX1 as a Novel Molecular Target for Breast Cancer
Nur Syamimi Ariffin
Clinical Breast Cancer (2022) Vol. 22, Iss. 6, pp. 499-506
Closed Access | Times Cited: 12
Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: Current status and future perspectives
Karishma Niveria, Monika Yadav, Kapil Dangi, et al.
OpenNano (2022) Vol. 8, pp. 100083-100083
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top